Evaluation of leptin and adiponectin levels in patients with stable angina pectoris

Masoud Mozafari1, Masoumeh Sadeghi, Hamid Sanei

  • 1Cardiology Resident, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

This study found no significant difference in leptin and adiponectin levels between patients with and without coronary artery disease. Further research is needed to confirm the roles of these hormones in cardiovascular health.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Syndrome

Background:

  • Leptin and adiponectin are key hormones secreted by adipose tissue.
  • Their roles in the development of cardiovascular diseases are under investigation.
  • Understanding these hormones' impact on coronary artery disease is crucial.

Purpose of the Study:

  • To investigate the relationship between serum leptin and adiponectin levels and coronary artery disease.
  • To determine if these adipokines are associated with the presence of coronary artery disease.

Main Methods:

  • Coronary angiography was performed on 170 patients diagnosed with angina pectoris.
  • Serum levels of leptin, adiponectin, and blood lipids were measured.
  • Data were analyzed using multivariate variance analysis with SPSS software.

Main Results:

  • 45.1% of patients exhibited positive angiographic findings for coronary artery disease.
  • Serum leptin and adiponectin levels were below the assay's minimum detection limits.
  • No significant differences in hormone levels were found between patients with and without coronary artery disease.
  • No significant correlation was observed between hormone levels and serum lipids.

Conclusions:

  • The study did not find a significant association between leptin, adiponectin, and coronary artery disease in the studied population.
  • Previous research suggests a correlation between high leptin and coronary artery disease, and a cardioprotective role for adiponectin.
  • Further comprehensive studies are required to validate these findings and clarify the roles of leptin and adiponectin in cardiovascular health.
Abstract

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...